Shandong Xinhua Pharmaceutical Co., Ltd

Hualu Network Group 中文版

Investor Relation

Information transparency and trust in peers

Investor Relation

INTERIM REPORT

Overseas Regulatory Announcement-Announcement in relation to obtaining of the Notification of Approval of Supplementary Drug Application and Other Relevant Information

Announcement Notice of Board Meeting

Overseas Regulatory Announcement-Announcement on Bumetanide Injection Having Obtained Drug Registration Certificate

Overseas Regulatory Announcement-Announcement on Sodium Potassium Magnesium and Calcium Concentrated Solution for Injection Having Obtained Drug Regis...

Overseas Regulatory Announcement-Announcement on Sodium Potassium Magnesium and Calcium Concentrated Solution for Injection Having Obtained Drug Regis...

Overseas Regulatory Announcement-Announcement in Relation to Obtaining of the Notification of Approval of Supplementary Drug Application and Other Relevant Information

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2026

Resignation of Non-executive Director

List of Directors And Their Roles And Functions

Final Dividend for the Year Ended 31 December 2025

Proposed Amendments to the Articles of Association

总条数: 79条

＜ 1 2 3 ... 8 ＞

跳转到: 页